Trial Profile
Phase II study of amrubicin in patients with previously treated small-cell lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Feb 2016
Price :
$35
*
At a glance
- Drugs Amrubicin (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 08 Feb 2016 New trial record